Why the study?
Does peri-procedural myonecrosis (creatine kinase MB elevation) after coronary stenting increase the risk of long-term major adverse ischaemic events and mortality in patients undergoing planned coronary stenting?
Population
3478 patients undergoing planned coronary stenting
Comparison
Peri-procedural myonecrosis stratified by peak… vs Normal creatine kinase MB levels
Design
Cohort
Follow-up
average 15+/-15 months (range 1-72)
Authors
Loading...
CK-MB elevation after stenting was associated with higher long-term mortality; extends prior observational data but leaves causal effects and practice change open.
Does peri-procedural myonecrosis (creatine kinase MB elevation) after coronary stenting increase the risk of long-term major adverse ischaemic events and mortality in patients undergoing planned coronary stenting?
Peri-procedural myonecrosis after coronary stenting is frequent and strongly associated with increased long-term mortality and major ischaemic events, particularly at >10x the upper limit of normal.
Sorin J. Brener (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: